(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LYNXBIO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

LYNXBIO

ST13

US500000088505451

Classe

10, 42, 44

Pedido

88505451

Registro

6267524

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

41

Atualização mais recente

12/03/2026

Tipo de marca

Verbal

Classes Nice

10, 42, 44

Data de depósito

09/07/2019

Data de registro

09/02/2021

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

09/02/2021

Última transação

12/03/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

22/11/2015

Primeiro uso no comércio

17/06/2016

Código do desenho

4

Tipo de titular

03

Localização do titular

San Diego, CA, US

Examinador

IN, SUNG HYUN

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Lynx Biosciences, Inc.

Representantes

Lynx Biosciences, Inc.

Classificação técnica

Classes Nice

Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 10

Medical apparatus for testing cell cultures from biopsies; apparatus for medical diagnostic testing in the fields of cancer and immunology

Classe 42

Research and development of medical testsassays utilizing cell cultures from biopsiesdrug developmentcellular therapies; research and development of cell-based oncology tests; medical laboratory services; medical testing in the fields of oncologyimmunologypersonalized medicine research focusing on treatment evaluationpatient analysisdrug development; providing medical and scientific research information in the fields of oncologyimmunologypersonalized medicine

Classe 44

Medical testing for diagnostic or treatment services; medical testingmonitoringreporting services for treatment option identification and patient management; providing information regarding personalized medicineprediction of clinical treatment responsepatient stratificationdisease evolution

Publicações

Histórico de despachos e eventos da marca no USPTO.

41 publicações encontradas

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

10/03/2026

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

10/03/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/02/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

27/02/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

27/02/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/02/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/02/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/02/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/02/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/02/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/01/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/01/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/12/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/12/2020

IUAF

USE AMENDMENT FILED

02/12/2020

EISU

TEAS STATEMENT OF USE RECEIVED

02/12/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/06/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

13/05/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

13/05/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

13/05/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

13/05/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

13/05/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/04/2020

PUBO

PUBLISHED FOR OPPOSITION

07/04/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

18/03/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

29/02/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/02/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/02/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/02/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

18/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

18/02/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

18/02/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

30/09/2019

GNRT

NON-FINAL ACTION E-MAILED

30/09/2019

CNRT

NON-FINAL ACTION WRITTEN

30/09/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

25/09/2019

DOCK

ASSIGNED TO EXAMINER

25/09/2019

ALIE

ASSIGNED TO LIE

23/09/2019

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

16/09/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

16/07/2019

NWAP

NEW APPLICATION ENTERED

12/07/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LYNXBIO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.